These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24025769)

  • 1. Stem cells: Down's syndrome link to ageing.
    Souroullas GP; Sharpless NE
    Nature; 2013 Sep; 501(7467):325-6. PubMed ID: 24025769
    [No Abstract]   [Full Text] [Related]  

  • 2. Usp16: key controller of stem cells in Down syndrome.
    Xu JC; Dawson VL; Dawson TM
    EMBO J; 2013 Oct; 32(21):2788-9. PubMed ID: 24076652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usp16 contributes to somatic stem-cell defects in Down's syndrome.
    Adorno M; Sikandar S; Mitra SS; Kuo A; Nicolis Di Robilant B; Haro-Acosta V; Ouadah Y; Quarta M; Rodriguez J; Qian D; Reddy VM; Cheshier S; Garner CC; Clarke MF
    Nature; 2013 Sep; 501(7467):380-4. PubMed ID: 24025767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral amyloidosis, ageing and Alzheimer's disease; a contribution from studies on Down's syndrome.
    Mann DM
    Neurobiol Aging; 1989; 10(5):397-9; discussion 412-4. PubMed ID: 2530459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-immunoreactive dystrophic neurites in Down's syndrome brains.
    Mattiace LA; Kress Y; Davies P; Ksiezak-Reding H; Yen SH; Dickson DW
    J Neuropathol Exp Neurol; 1991 Sep; 50(5):547-59. PubMed ID: 1654399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reductions in soluble brain proteins in older subjects with Down's syndrome.
    Borthwick NM; Gordon A; Yates CM
    J Neurol Sci; 1985 May; 68(2-3):205-14. PubMed ID: 3159852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle stem cell dysfunction impairs muscle regeneration in a mouse model of Down syndrome.
    Pawlikowski B; Betta ND; Elston T; Williams DA; Olwin BB
    Sci Rep; 2018 Mar; 8(1):4309. PubMed ID: 29523805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
    Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
    Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing Trisomy 21 with XIST in Neural Stem Cells Promotes Neuronal Differentiation.
    Czermiński JT; Lawrence JB
    Dev Cell; 2020 Feb; 52(3):294-308.e3. PubMed ID: 31978324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies raised against different portions of A4 protein identify a subset of plaques in Down's syndrome.
    Spargo E; Luthert PJ; Anderton BH; Bruce M; Smith D; Lantos PL
    Neurosci Lett; 1990 Jul; 115(2-3):345-50. PubMed ID: 2146532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intersectin 1 contributes to phenotypes in vivo: implications for Down's syndrome.
    Hunter MP; Nelson M; Kurzer M; Wang X; Kryscio RJ; Head E; Pinna G; O'Bryan JP
    Neuroreport; 2011 Oct; 22(15):767-72. PubMed ID: 21876463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study.
    Bahn S; Mimmack M; Ryan M; Caldwell MA; Jauniaux E; Starkey M; Svendsen CN; Emson P
    Lancet; 2002 Jan; 359(9303):310-5. PubMed ID: 11830198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-100 immunoreactive interdigitating cells in normal and in Down's syndrome human thymuses.
    Aita M; Franzé A; Gabrielli F
    Cell Biol Int Rep; 1991 Aug; 15(8):645-59. PubMed ID: 1835904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome.
    Miyakawa T; Watanabe K; Katsuragi S
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(2):99-106. PubMed ID: 2878535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myofibers in tongues of Down's syndrome.
    Yarom R; Sagher U; Havivi Y; Peled IJ; Wexler MR
    J Neurol Sci; 1986 May; 73(3):279-87. PubMed ID: 2941522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impression cytology in Down's syndrome.
    Filippello M; Cascone G; Zagami A; Scimone G
    Br J Ophthalmol; 1997 Aug; 81(8):683-5. PubMed ID: 9349158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurogenesis impairment: An early developmental defect in Down syndrome.
    Stagni F; Giacomini A; Emili M; Guidi S; Bartesaghi R
    Free Radic Biol Med; 2018 Jan; 114():15-32. PubMed ID: 28756311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional aspects of Down's syndrome with special reference to the nervous system.
    Sylvester PE
    Br J Psychiatry; 1984 Aug; 145():115-20. PubMed ID: 6235883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of anti-keratins and anti-thymostimulin antibodies in normal and in Down's syndrome human thymuses.
    Aita M; Amantea A
    Thymus; 1991 May; 17(3):155-65. PubMed ID: 1712130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.